找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Quality Management and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy; The JACIE Guide Mahmoud Aljurf,John A

[復(fù)制鏈接]
樓主: 小費(fèi)
31#
發(fā)表于 2025-3-26 23:46:03 | 只看該作者
32#
發(fā)表于 2025-3-27 01:35:02 | 只看該作者
Personnel Requirements Including Job Descriptions,ous development of their competencies. Job descriptions for personnel should not be limiting and should support continuous professional development. In addition, accurate and frequent communication will increase cooperation within cellular therapy centres, minimise margins of error and contribute positively to patient care.
33#
發(fā)表于 2025-3-27 06:01:16 | 只看該作者
34#
發(fā)表于 2025-3-27 11:41:10 | 只看該作者
Tracking and Traceability,ogether will form an ‘information environment’. Together with electronic standards such as ISBT128 and Eurocode, this will further enhance safety, accuracy and efficiency in tracking and tracing cellular products.
35#
發(fā)表于 2025-3-27 14:54:01 | 只看該作者
Training Programme,rocedures as well as cooperate with personnel from other disciplines. Staff training plays a key role in the implementation of cell therapy and in QM. New cell therapy applications are constantly being developed. Appropriate training of personnel will improve both the effectiveness of cell therapy and patient survival.
36#
發(fā)表于 2025-3-27 17:52:12 | 只看該作者
Quality and Standards for Haematopoietic Stem Cells Transplantation Programs,transplantation professionals have been continuously developing and improving standards to help control this complexity and manage the inherent risks of this treatment. In this regard, HSCT was, and continues to be, a pioneer in the area of quality and standards.
37#
發(fā)表于 2025-3-28 01:17:19 | 只看該作者
38#
發(fā)表于 2025-3-28 04:38:39 | 只看該作者
Adverse Events and Corrective and Preventive Actions, in this case, the transplant programme quality system should have specific SOP that includes a system to manage any issues, actions to prevent adverse events and deviations, and a description of the step to resolve them.
39#
發(fā)表于 2025-3-28 10:02:56 | 只看該作者
Risk Management,by whom, why, how, and when this approach should be applied in order to benefit the production and use of safe and effective cell-based therapies in general and hematopoietic stem cell transplantation in particular.
40#
發(fā)表于 2025-3-28 13:49:37 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 17:22
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
芜湖县| 丹阳市| 五原县| 鄂州市| 苍溪县| 天等县| 靖州| 高碑店市| 湖口县| 行唐县| 榆社县| 宽城| 中西区| 日土县| 保靖县| 柳州市| 兰考县| 孙吴县| 句容市| 沙田区| 长丰县| 清原| 肥西县| 鹤山市| 本溪市| 祥云县| 溧水县| 冷水江市| 疏附县| 来安县| 修武县| 青河县| 柳江县| 汝城县| 陵水| 青海省| 化德县| 视频| 辉南县| 定陶县| 宁陕县|